WEINSTEIN ROBERT - Insider Non-Derivative Transactions at PharmaCyte Biotech, Inc. (PMCB) - (SEC)

Updated on March 12, 2026.

According to recent SEC insider information filed on Dec 12, 2025, WEINSTEIN ROBERT's relationship to PharmaCyte Biotech, Inc. (PMCB) is Director, and currently has 75,000 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other PMCB insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

WEINSTEIN ROBERT - Insider Non-Derivative Transactions of PMCB Common Stock

WEINSTEIN ROBERT - Insider Non-Derivative Transactions at PMCB

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Dec 13, 2025	F -- (Common Stock)	33750	1.02	41250
Dec 13, 2025	Acquisition -- (Common Stock)	75000	0	75000